Ecuphar is an Ethical, Caring and Understanding company with a Passion for providing high-quality Healthcare products and services for veterinarians and Animal owners worldwide, and with a commitment to Research and development.
ECUPHAR is a company devoted to the development and marketing of a broad range of products and services with added value for veterinarians and animal owners.
The company has several subsidiaries and business units that are involved in different activities within the animal health industry:
Marketing & Distribution
Research & Development
05/05/2015 - ECUPHAR enters the Spanish and southern European markets through ESTEVE
The Belgian company acquires ESTEVE veterinary division and aspires to lead the European market in the segment of animal health in the coming years.
The complete press release can be downloaded here.
More info in this AnimalPharm Article (06/05/2015)
14/02/2015 - Pieter Devos takes a win in Hong Kong
Belgian Pieter Devos seems to be in a perfect mood in Asia. Last year he won the Longines Global Champions Tour Grand Prix in Shanghai. This time he wins the 1m45 competition of the Masters Grand Slam in Hong Kong.
Aboard the 12-years-old Equipharma Dax van 'Dabdijhoeve (by Desir du Chateau) Devos was only some hunderst of seconds faster as Marco Kutscher and Van Gogh (by Numero Uno). The Dutch Champions-pair, Maikel Van der Vleuten and VDL Groep Eureka (by Chin Chin) concluded with a third spot.
28/12/2014 - Ecuphar's rider Pieter Devos wins the Championship on Jumping Mechelen
In the KBC trial, a 1m50 with jump-off, 41 riders started, 13 of which managed to push on to the jump-off. The victory went to Pieter Devos and Dream of India Greenfield. No surprise, because Peter won already in June with the eleven year-old BWP the Grand Prix of the Global Champions Tour in Shanghai.
04/07/2014 - Ecuphar sponsort opnieuw de laureaat voor de prijs Masterproef Optie Onderzoek
Dit jaar was Chloë De Witte de gelukkige met haar thesis over
de interacties tussen Helicobacter suis en de maagmicroflora van het varken: mogelijke implicaties voor de ontwikkeling van een anti-"H. suis" therapie